Dr. Surbhi Sidana, MD
Claim this profileStanford University
Studies Multiple Myeloma
Studies Non-Hodgkin's Lymphoma
6 reported clinical trials
11 drugs studied
Area of expertise
1Multiple Myeloma
2Non-Hodgkin's Lymphoma
Philadelphia Chromosome positive
CD22 positive
CD22 negative
Affiliated Hospitals
Clinical Trials Surbhi Sidana, MD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting1 award Phase 1
Wearable Sensors
for Blood Cancers
The purpose of this study is to monitor physiological and molecular changes during and following CAR-T cancer cell therapy, towards improved management of adverse events including Cytokine Release Syndrome and neurotoxicity. Our study aims are to improved early detection and precise management of adverse events for patients receiving Chimeric antigen receptor T- cell (CAR-T): 1. To assess the feasibility, including accuracy, usability, and usefulness of wearable sensors in CAR-T patients. 2. To generate comprehensive multiomic profile analysis following CAR-T therapy. 3. To perform integrated analysis of wearables sensor data, omics data, and symptom/clinical data.
Recruiting1 award N/A5 criteria
More about Surbhi Sidana, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Surbhi Sidana, MD has experience with
- Cyclophosphamide
- Biostrap Arm Band
- Lenalidomide
- Talquetamab
- PHE885
- CD22 CAR
Breakdown of trials Surbhi Sidana, MD has run
Multiple Myeloma
Non-Hodgkin's Lymphoma
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Surbhi Sidana, MD specialize in?
Surbhi Sidana, MD focuses on Multiple Myeloma and Non-Hodgkin's Lymphoma. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Surbhi Sidana, MD currently recruiting for clinical trials?
Yes, Surbhi Sidana, MD is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Surbhi Sidana, MD has studied deeply?
Yes, Surbhi Sidana, MD has studied treatments such as Cyclophosphamide, Biostrap arm band, Lenalidomide.
What is the best way to schedule an appointment with Surbhi Sidana, MD?
Apply for one of the trials that Surbhi Sidana, MD is conducting.
What is the office address of Surbhi Sidana, MD?
The office of Surbhi Sidana, MD is located at: Stanford University, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.